Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease

An Author Correction to this article was published on 20 December 2017

This article has been updated

Mouse models have generally failed to recapitulate the dopaminergic neurodegeneration seen in Parkinson's disease. Expressing mutant α-synuclein in a background of elevated dopamine generates mice with nigrostriatal degeneration.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Schematic of a dopaminergic neuron with striatal synaptic terminals.

Change history

  • 20 December 2017

    In the version of this article initially published, the molecular mass of synuclein was given as 140 kDa instead of 14 kDa. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Mor, D.E. et al. Nat. Neurosci. 20, 1560–1568 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Graham, D.G. Mol. Pharmacol. 14, 633–643 (1978).

    CAS  PubMed  Google Scholar 

  3. Hastings, T.G., Lewis, D.A. & Zigmond, M.J. Proc. Natl. Acad. Sci. USA 93, 1956–1961 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Conway, K.A., Rochet, J.C., Bieganski, R.M. & Lansbury, P.T. Jr. Science 294, 1346–1349 (2001).

    Article  CAS  PubMed  Google Scholar 

  5. Wang, L. et al. Curr. Biol. 24, 2319–2326 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Burré, J. et al. Science 329, 1663–1667 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Nemani, V.M. et al. Neuron 65, 66–79 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Vargas, K.J. et al. Cell Rep. 18, 161–173 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Busch, D.J. et al. Mol. Biol. Cell 25, 3926–3941 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Scott, D.A. et al. J. Neurosci. 30, 8083–8095 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Scott, D. & Roy, S. J. Neurosci. 32, 10129–10135 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kirik, D. et al. Proc. Natl. Acad. Sci. USA 100, 2884–2889 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kramer, M.L. & Schulz-Schaeffer, W.J. J. Neurosci. 27, 1405–1410 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Choi, B.K. et al. Proc. Natl. Acad. Sci. USA 110, 4087–4092 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Martinez-Vicente, M. et al. J. Clin. Invest. 118, 777–788 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Subhojit Roy.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roy, S. Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease. Nat Neurosci 20, 1514–1515 (2017). https://doi.org/10.1038/nn.4660

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn.4660

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing